Kittiphan Chienwichai

Dr. Kittiphan Chienwichai

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 July 2025 in Kidney360
Verified
Journal Article
Open access
KCKittiphan Chienwichai
Kittiphan Chienwichai
SJSirin Jiwakanon
Sirin Jiwakanon
KCKamonrat Chaiviriyawong
Kamonrat Chaiviriyawong
JWJananya Wattanakul
Jananya Wattanakul
WRWarat Rojnsaengroung
Warat Rojnsaengroung
PMPannawat Mongkolrattanakul
Pannawat Mongkolrattanakul
Key Points: The Furst equation helps identify patients at risk of fluid restriction failure in syndrome of inappropriate antidiuresis, although its predictive performance is limited. Additional urinary biomarkers beyond the Furst equation may not improve the prediction of fluid restriction response. Background: The syndrome of inappropriate antidiuresis (SIAD) is a common cause of hyponatremia in hospitalized patients, with fluid restriction (FR) as the first-line treatment. However, up to 50% of patients fail to respond to FR, highlighting the need for reliable predictors of treatment failure. Therefore, this study aimed to evaluate the predictive performance of urinary biomarkers, including the Furst equation (the ratio of the sum of urinary sodium and potassium concentrations to plasma sodium), urine osmolality, and urine output, in identifying nonresponders to FR. Methods: This prospective multicenter cohort study was conducted at two medical centers in Thailand from September 2022 to June 2024 and included 79 hospitalized patients with SIAD. Response to FR was defined as an increase in serum sodium level of ≥3 mEq/L by day 4, with no decrease in serum sodium levels at any point during the FR period. Predictive performance was assessed using sensitivity, specificity, and area under the receiver operating characteristic curve (AUC) for each biomarker. Multivariable logistic regression analysis incorporating all urinary biomarkers was also performed. Results: Overall, 59% of patients failed to respond to FR by day 4, and adherence to FR was modest (72%). The Furst equation demonstrated the best predictive performance, with an optimal cutoff of 0.86 (sensitivity: 55.3%; specificity: 70.2%, AUC: 0.65). Combining the Furst equation with urine osmolality and urine output improved specificity to 91.0%, although sensitivity decreased to 32.3%. A multivariable logistic regression model achieved similar discrimination (AUC: 0.67) compared with the Furst equation alone. Conclusions: Although the Furst equation can identify nonresponders to FR, its predictive performance is limited. Our findings suggest that other urinary biomarkers beyond the Furst equation may not improve overall predictive accuracy for predicting nonresponse to FR. These findings highlight the need for more effective predictive tools. Further studies are warranted to validate these results and optimize treatment strategies for SIAD. Clinical Trial registry name and registration number: Thai Clinical Trials Registry, TCTR20221206001.

3 April 2026 in Clinical Kidney Journal
Verified
Journal Article
Open access
KCKittiphan Chienwichai
Kittiphan Chienwichai
PLPitsinee Laipanngam
Pitsinee Laipanngam
SJSirin Jiwakanon
Sirin Jiwakanon
KCKamonrat Chaiviriyawong
Kamonrat Chaiviriyawong
JWJananya Wattanakul
Jananya Wattanakul
PMPannawat Mongkolrattanakul
Pannawat Mongkolrattanakul
Background: Syndrome of inappropriate antidiuresis (SIAD) is a common cause of hyponatraemia, with fluid restriction (FR) failing in nearly half of patients. Although furosemide combined with oral sodium chloride (NaCl) tablets is widely used as second-line therapy, evidence supporting its effectiveness after FR failure remains limited, and predictors of response have not been established. Methods: This prospective multicentre cohort study enrolled hospitalized adults with SIAD who failed FR at two tertiary centres in Thailand between October 2022 and September 2025. Patients received oral NaCl tablets (3.6 g daily) and furosemide (40 mg daily) while continuing FR. The primary outcome was the daily rate of serum sodium correction. Predictors of response were identified using multivariable linear mixed-effects models. Results: Among 88 patients (68% male; median age 65 years), the median baseline serum sodium was 124 mmol/l. Serum sodium increased by 1.51 mmol/l per day [95% confidence interval (CI) 1.37–1.66], reaching a median of 130 mmol/l by day 4 and 134 mmol/l by day 7. Three factors independently predicted faster correction: higher body weight (β 0.85 mmol/l per 10 kg; 95% CI 0.28–1.42), lower baseline sodium (β −0.58 per 1 mmol/l lower; 95% CI −0.77 to −0.39), and drug-induced aetiology (β 7.17 mmol/l; 95% CI 3.48–10.85). Adverse events included hypokalaemia (51%), hypomagnesaemia (29.5%), and acute kidney injury (18.2%). Overcorrection occurred in one (1.1%) patient. Conclusions: Furosemide combined with oral NaCl tablets is a practical second-line option for SIAD after FR failure, achieving sodium correction of 1.5 mmol/l per day. Higher body weight, lower baseline sodium, and drug-induced aetiology predict faster correction. Randomized controlled trials are needed to confirm efficacy.

2 May 2025 in BMC Nephrology
Verified
Journal Article
Open access
PMPannawat Mongkolrattanakul
Pannawat Mongkolrattanakul
KCKittiphan Chienwichai
Kittiphan Chienwichai
Background: To evaluate the effectiveness of a Shared Decision-Making (SDM) program in reducing unplanned dialysis among patients with advanced chronic kidney disease (CKD) and to identify factors predictive of unplanned dialysis. Methods: This retrospective cohort study was conducted at Phanatnikhom Hospital in Chonburi, Thailand, from October 2021 to September 2023. Patients aged 18 years and older with CKD stages 4 and 5 who were receiving renal replacement therapy (RRT) were included. Starting in October 2022, the Shared Decision-Making (SDM) program was implemented as the standard of care. Baseline demographic data, dialysis modalities, and the incidence of unplanned dialysis were collected. Unplanned dialysis was defined as dialysis initiated through a temporary catheter or within a short time frame after the initial dialysis decision. Results: Among 111 patients, 66 received SDM, and 45 received usual care. The incidence of unplanned dialysis was significantly lower in the SDM group compared to the usual care group (33.3% vs. 66.7%, p < 0.001). Multivariate analysis indicated that participation in the SDM program (OR = 0.19, p = 0.001), peritoneal dialysis (OR = 0.26, p = 0.032), and higher serum albumin at the initiation of dialysis (OR = 0.33, p = 0.014) were protective factors against unplanned dialysis. Conclusions: The SDM program effectively reduces unplanned dialysis in patients with advanced CKD by aligning medical decisions with patient preferences and priorities. Peritoneal dialysis and higher serum albumin levels at dialysis initiation are also associated with lower rates of unplanned dialysis.

7 August 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
KCKittiphan Chienwichai
Kittiphan Chienwichai
SJSirin Jiwakanon
Sirin Jiwakanon
KCKamonrat Chaiviriyawong
Kamonrat Chaiviriyawong
JWJananya Wattanakul
Jananya Wattanakul
WRWarat Rojnsaengroung
Warat Rojnsaengroung
PMPannawat Mongkolrattanakul
Pannawat Mongkolrattanakul
Accurately distinguishing hypovolemic hyponatremia from the syndrome of inappropriate antidiuresis (SIAD) remains challenging due to limitations in traditional pre-saline infusion urine sodium measurements. This prospective cohort study at two Thai medical centers evaluated whether post-saline infusion urine sodium improves diagnostic accuracy. We enrolled 113 hospitalized adults with non-edematous hypotonic hyponatremia (serum sodium < 130 mmol/L). Asymptomatic patients received 500 mL of 0.9% saline, while symptomatic patients received 150 mL of 3% saline. Urine sodium was measured before and after infusion (Time 1). Diagnostic performance was assessed using AUC curves, with Youden’s J statistic determining optimal cutoffs. Post-infusion urine sodium at Time 1 demonstrated superior accuracy compared to pre-infusion measurements (AUC 0.75 vs. 0.61, P = 0.01). A cutoff of 24.5 mmol/L at Time 1 achieved 75.2% accuracy (95% CI: 66.2–82.9), 62.5% sensitivity (95% CI: 45.8–77.3), and 82.2% specificity (95% CI: 71.5–90.2). These findings highlight the clinical utility of post-saline urine sodium. In conclusion, measuring urine sodium after saline infusion significantly improves differentiation between hypovolemic hyponatremia and SIAD compared to pre-infusion testing. The 24.5 mmol/L cutoff at Time 1 offers a practical, evidence-based threshold for clinicians, reducing misdiagnosis risks and guiding appropriate fluid management in hyponatremic patients.

Verified
Journal Article
Open access
PDF file
AKAraya Khaimook
Araya Khaimook
KCKittiphan Chienwichai
Kittiphan Chienwichai
ACArunchai Chang
Arunchai Chang
Background: The clinical significance of Helicobacter pylori (H. pylori) infection in acute non-variceal upper gastrointestinal bleeding (NVUGIB) remains uncertain, particularly regarding short-term outcomes beyond rebleeding. Methods: We conducted a single-center retrospective cohort study of consecutive adults admitted with acute NVUGIB to Hatyai Hospital, Thailand, between January 2016 and December 2020. H. pylori status was determined during the index hospitalization using rapid urease testing and/or histopathologic examination of gastric biopsy specimens obtained during upper gastrointestinal endoscopy. The primary outcome was 30-day all-cause mortality. Secondary outcomes included in-hospital mortality, rebleeding, requirement of packed red blood cell transfusion, and length of hospital stay. Multivariable regression analyses were performed to adjust for potential confounders. Results: Among 933 patients, 289 (31.0%) were H. pylori-positive and 644 (69.0%) were H. pylori-negative. The H. pylori-positive group was younger, predominantly male, and had lower rates of cirrhosis and prior proton pump inhibitor use. They also more often had peptic ulcer bleeding and underwent earlier endoscopy. H. pylori positivity was independently associated with lower 30-day mortality (adjusted odds ratio 0.39, 95% confidence interval 0.18–0.84), but not with rebleeding, requirement of transfusion, or length of stay. Conclusions: H. pylori positivity was associated with lower short-term mortality in acute NVUGIB, although this finding may reflect baseline clinical differences rather than a direct effect on bleeding severity.

9 January 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
KCKittiphan Chienwichai
Kittiphan Chienwichai
SJSirin Jiwakanon
Sirin Jiwakanon
KCKamonrat Chaiviriyawong
Kamonrat Chaiviriyawong
JWJananya Wattanakul
Jananya Wattanakul
TSThanapong Sungworawongpana
Thanapong Sungworawongpana
SPSongklod Pakdeejit
Songklod Pakdeejit
Background/Objectives: Despite the widespread recognition of preprocedural anxiety in awake invasive procedures, there is a paucity of data examining its prevalence and clinical impact in patients undergoing percutaneous kidney biopsy. This study aimed to determine the prevalence of preprocedural anxiety, assess its association with peri-procedural hemodynamic parameters, and identify factors associated with elevated anxiety. Methods: In this prospective observational study, 151 adults scheduled for percutaneous kidney biopsy between June 2023 and January 2025 were enrolled. Anxiety was assessed 24 h before the procedure using the Thai State–Trait Anxiety Inventory Y1 (STAI-Y1). Blood pressure and pulse rate were measured at baseline and 30 min before biopsy. Mixed-effects models evaluated associations between anxiety and hemodynamic changes, and logistic regression identified predictors of anxiety. Results: Clinically significant anxiety (STAI-Y1 ≥ 40) was present in 55% of patients, with 43.4% reporting very high anxiety. Anxiety status was not independently associated with changes in systolic or diastolic blood pressure or pulse rate. However, diastolic blood pressure increased significantly from baseline to preprocedural across all patients (mean increase 5.45 mmHg; p = 0.008), irrespective of anxiety. Higher serum creatinine (OR 1.29; p = 0.012) and a history of previous kidney biopsy (OR 4.28; p = 0.004) were independently associated with anxiety. Conclusions: Preprocedural anxiety is highly prevalent among patients undergoing kidney biopsy but does not independently influence peri-procedural hemodynamic parameters. Targeted screening and supportive interventions may benefit patients at increased risk of anxiety.